Clinical Trial News | BioPharma Dive
WEB5 days ago — The latest clinical trial news for biotech and biopharmaceutical professionals
10 clinical trials to watch in the first half of 2024 - BioPharma Dive
WEBJan 2, 2024 — 10 clinical trials to watch in the first half of 2024 Study results from Vertex, Alnylam and Roche could either speed or stall biotech’s recent momentum.
Summit lung cancer drug shows ‘striking’ benefit over Keytruda
WEBSep 8, 2024 — Summit lung cancer drug shows ‘striking’ benefit over Keytruda. Study results showed Summit’s drug cut the risk of lung cancer progression or death by half compared to Keytruda, a finding doctors described as impressive. Summit Therapeutics tested its drug ivonescimab against Keytruda in people with previously untreated lung cancer.
Novo fills in positive picture for preventive hemophilia drug
WEBJun 24, 2024 — Novo fills in positive picture for preventive hemophilia drug Detailed data from a Phase 3 trial of the company’s “Mim8” drug showed treatment controlled bleeding at both once-weekly and once-monthly doses.
Merck claims late-stage study success for RSV antibody
WEBJul 23, 2024 — An experimental Merck & Co. drug designed to protect infants from illness caused by respiratory syncytial virus succeeded in a late-stage trial, the company said Tuesday. In a statement, Merck said the therapy, an antibody called clesrovimab, met its main safety and efficacy objectives in a placebo-controlled trial involving more than 3,600 ...
Biotech and Pharma Industry News | BioPharma Dive
WEBBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Roche, following setbacks, turns to its next Alzheimer’s drug
WEBMar 11, 2024 — Roche said its experimental Alzheimer’s disease drug trontinemab showed it might be able to clear brain plaques faster than other medicines.
Keytruda fails lung and skin cancer trials, limiting further expansion
WEBAug 29, 2024 — Merck & Co.’s drug Keytruda failed to help people with cancer in two clinical trials, both using the immunotherapy as an add-on to other types of treatment for early-stage lung and skin cancer, the comapny said Thursday. Both trials were stopped early following the recommendation of independent data analysts, who …
Novo’s latest obesity pill spurs major weight loss in small trial
WEBMar 7, 2024 — An experimental pill developed by Novo Nordisk helped obese people lose 13% of their body weight after three months of treatment in a small clinical trial, the company said Thursday, in a result one analyst described as among the best of any weight loss drug tested so far. The drug, called amycretin, is one of a …
Apellis plans FDA filing after drug success in kidney trial
WEBAug 8, 2024 — Apellis plans FDA filing after drug success in kidney trial Analysts at Evercore ISI called pegcetacoplan’s data in two kidney conditions a “left-field hit” that compare favorably to results for a Novartis treatment.